Literature DB >> 23137026

O2-functionalized methylamine diazeniumdiolates: evidence for E ⇄ Z equilibration in an acyclic system.

Debanjan Biswas1, Ryan J Holland, Jeffrey R Deschamps, Zhao Cao, Larry K Keefer, Joseph E Saavedra.   

Abstract

Diazeniumdiolates that have the structure RHN-N(O)═NOR' are of interest as prodrug (caged) forms of the bioeffectors nitric oxide (NO) and nitroxyl (HNO). Previous work has focused on examples possessing α-branched R groups, with isopropylamine (IPA)/NO (R = isopropyl) being the smallest examined to date. To probe the effect of minimizing the alkyl-group size on the chemistry of IPA/NO, we prepared the corresponding methylamine derivative as a sodium salt that was highly unstable but could be trapped in very low overall yield as the stable O(2)-benzyl derivative. To prepare enough for efficient characterization, we devised an alternate synthesis involving a novel N-dealkylation route. CH(3)HN-N(O)═NOBn, synthesized in high yield and crystallized as the Z isomer as determined by X-ray crystallography, was observed to exist as a 11:1 mixture of two isomeric forms in dynamic equilibrium in solution. Similar results were seen for the O(2)-ethyl derivative, whose two equilibrium constituents were partially separated by HPLC to reveal essentially identical UV and mass spectra, indicating them to be Z and E isomers of CH(3)HN-N(O)═NOEt. The results could lead the way to a fuller understanding of the chemistry of the acyclic (E)-diazeniumdiolates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137026      PMCID: PMC7243909          DOI: 10.1021/jo3020837

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  22 in total

Review 1.  Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development.

Authors:  Ferid Murad
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

Review 2.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 3.  Nitroxyl (HNO) signaling.

Authors:  Jon M Fukuto; Christopher L Bianco; Tyler A Chavez
Journal:  Free Radic Biol Med       Date:  2009-06-17       Impact factor: 7.376

4.  "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

Authors:  L K Keefer; R W Nims; K M Davies; D A Wink
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

Review 5.  A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species.

Authors:  Michael G Espey; Katrina M Miranda; Douglas D Thomas; Sandhya Xavier; Deborah Citrin; Michael P Vitek; David A Wink
Journal:  Ann N Y Acad Sci       Date:  2002-05       Impact factor: 5.691

6.  Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.

Authors:  Carlos A Velázquez; Qiao-Hong Chen; Michael L Citro; Larry K Keefer; Edward E Knaus
Journal:  J Med Chem       Date:  2008-02-29       Impact factor: 7.446

7.  Mechanism of pH-dependent decomposition of monoalkylamine diazeniumdiolates to form HNO and NO, deduced from the model compound methylamine diazeniumdiolate, density functional theory, and CBS-QB3 calculations.

Authors:  Andrew S Dutton; Christopher P Suhrada; Katrina M Miranda; David A Wink; Jon M Fukuto; K N Houk
Journal:  Inorg Chem       Date:  2006-03-20       Impact factor: 5.165

8.  Traube's "oxazomalonic acid" is a 3-hydroxysydnone carboxylate with an E-ONNO geometry.

Authors:  Navamoney Arulsamy; D Scott Bohle
Journal:  Angew Chem Int Ed Engl       Date:  2002-06-17       Impact factor: 15.336

Review 9.  Nitric oxide and superoxide: interference with hypoxic signaling.

Authors:  Bernhard Brüne; Jie Zhou
Journal:  Cardiovasc Res       Date:  2007-03-14       Impact factor: 10.787

Review 10.  Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances.

Authors:  Larry K Keefer
Journal:  ACS Chem Biol       Date:  2011-09-30       Impact factor: 5.100

View more
  2 in total

1.  Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors:  Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2014-09-02       Impact factor: 4.427

2.  Decoding nitric oxide release rates of amine-based diazeniumdiolates.

Authors:  Yan-Ni Wang; Jack Collins; Ryan J Holland; Larry K Keefer; Joseph Ivanic
Journal:  J Phys Chem A       Date:  2013-07-23       Impact factor: 2.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.